2 stories mentioning HKG:9606Updated 19d ago
Every FINWIRES story that references HKG:9606, newest first.
Duality Biotherapeutics (HKG:9606) said the Shanghai Stock Exchange accepted the application materials for the proposed share issue and listing on the Science and Technology Innovation Board, according to a Friday Hong Kong bourse filing.Shares of the biotechnology company were up over 3% in Monday's late-morning trade.
Duality Biotherapeutics (HKG:9606) announced plans to buy back up to $40 million worth of its shares from the open market, according to a Tuesday filing with the Hong Kong bourse.The biopharmaceutical firm's shares gained over 3% in morning trade on Wednesday.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.Meanwhile, Duality Bio Chairman and Chief Executive Officer Zhu Zhongyuan plans to increase his shareholding in the company by spending up to $5 million to buy shares in the secondary market.
